B. Riley Wealth Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

B. Riley Wealth Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,732	Closed	-$16.2K	–	1643
2024 Q1	$16.2K	Buy	+12,732	New	+$16.2K	﹤0.01%	1431
2023 Q4	–	Sell	-12,732	Closed	-$16.2K	–	1531
2023 Q3	$16.2K	Buy	+12,732	New	+$11.1K	﹤0.01%	1431

B. Riley Wealth Advisors's ZYNE Position: Q2 2024 in Review

B. Riley Wealth Advisors sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2024, closing a stake of 12,732 shares — an estimated $16.2K sold.

B. Riley Wealth Advisors first reported a position in ZYNE in Q3 2023 and held it in 2 quarters. The position peaked at $16.2K in Q1 2024. 0 funds tracked by Wall St. Rank hold ZYNE as of Q2 2024.

B. Riley Wealth Advisors reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
B. Riley Wealth Advisors sold 12,732 Zynerba Pharmaceuticals, Inc shares in Q2 2024, an estimated $16.2K.
B. Riley Wealth Advisors first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2023 and held it in 2 quarters.
B. Riley Wealth Advisors's Zynerba Pharmaceuticals, Inc position peaked at $16.2K in Q1 2024.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2024, filed 19 Aug 2024.